Irina Proskorovsky et al <br/><br/>
Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works